Drug Trial Radar · NCT04944862
A Study of CDX-0159 in Patients With Prurigo Nodularis
Last checked: Nov 20, 2026Latest source record: Aug 14, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
24
Actual
Start
Nov 8, 2021
Primary completion
Jul 31, 2023
Study completion Jul 31, 2023
Sponsor
- Lead sponsor
- Celldex TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Jun 30, 2021
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to explore the safety, clinical effect, pharmacodynamics, and pharmacokinetics of CDX-0159 (barzolvolimab) in patients with Prurigo Nodularis.
Conditions
- Prurigo Nodularis
Interventions
CDX-0159Biological
administered intravenously
Normal salineDrug
administered intravenously
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety and tolerability as assessed by the incidence and severity of adverse eventsTime frame: From Day 1 (first dose) to Day 169 (last follow-up visit)
Locations
17 sites in 3 countries. Site status is shown where the registry gives one.
Desert Sky Dermatology
Tempe, Arizona
University of Miami, Dermatology Clinical Trials Unit
Miami, Florida
Revival Research Institute, LLC
Troy, Michigan
University of New Mexico
Albuquerque, New Mexico
Markowitz Medical/Optiskin
New York, New York
Central Sooner Research
Norman, Oklahoma
Center for Clinical Studies, LTD.LLP
Houston, Texas
Charité Centrum für Innere Medizin und Dermatologie, Institute of Allergology (IFA)
Berlin, Germany
Katholisches Klinikum Bochum gGmbH, Dermatologische Studienambulanz
Bochum, Germany
Universitatsklinikum Carl Gustav Carus Dresden, Klinik und Poliklinik fur Dermatologie
Dresden, Germany
Universitätsklinikum Frankfurt Klinik für Dermatologie, Venerologie und Allergologie Klinische Forschung
Frankfurt, Germany
Universitätsklinikum Erlangen Hautklinik
Mainz, Germany
Universitätsmedizin der Johannes Gutenberg-Universität Mainz Hautklinik, Clinical Research Center
Mainz, Germany
Universitaetsklinikum Muenster (UKM) - Klinik für Hautkrankheiten
Münster, Germany
MT Medic Specjalistyczna Praktyka Lekarska
Krosno, Poland
IP Clinic Sp. z o.o.
Lodz, Poland
Centrum Medyczne Ginemedica
Wroclaw, Poland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.